Cetuximab or cisplatin as a radiosensitizer in locoregionally advanced head and neck cancer: recent results

被引：2
|
作者：
Bonner, James A. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35249 USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷 / 03期
关键词：
SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; RADIATION-THERAPY; CONCURRENT CHEMORADIOTHERAPY; INFUSION REACTIONS; NORTH-CAROLINA; RADIOTHERAPY; CHEMOTHERAPY;
D O I：
10.21037/tcr.2016.06.22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：234 / 237
页数：4
相关论文
共 50 条
  • [41] Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer
    Seiwert, Tanguy Y.
    Melotek, James M.
    Blair, Elizabeth A.
    Stenson, Kerstin M.
    Salama, Joseph K.
    Witt, Mary Ellyn
    Brisson, Ryan J.
    Chawla, Apoorva
    Dekker, Allison
    Lingen, Mark W.
    Kocherginsky, Masha
    Villaflor, Victoria M.
    Cohen, Ezra E. W.
    Haraf, Daniel J.
    Vokes, Everett E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (01): : 21 - 29
  • [42] Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
    Jeong, Il Seok Daniel
    Mo, Huan
    Nguyen, Anthony
    Chong, Esther G.
    Tsai, Hsin Hsiang Clarence
    Moyers, Justin
    Kim, Matthew
    Lacy, Curtis
    Shah, Vivek
    Lau, Eric
    Xu, Yi
    Cao, Huynh
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2020, 9 (01)
  • [43] Comparative Effectiveness and Toxicity of Cetuximab or Cisplatin With Concurrent Radiation for Locoregionally Advanced Squamous Cell Carcinoma of The Head And Neck: A Population-Based Analysis
    Xiang, Michael
    Holsinger, Floyd Christopher
    Chen, Michelle
    Colevas, Alexander Dimitrios
    Beadle, Beth Michelle
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E16 - E16
  • [44] Treatment Outcome of Cetuximab Compared with Cisplatin during Radical Radiotherapy for Locally Advanced Head and Neck Cancer
    Law, K. S.
    Wong, R. K. Y.
    Yu, E.
    Cheng, A. C. K.
    [J]. HONG KONG JOURNAL OF RADIOLOGY, 2016, 19 (02): : 96 - 102
  • [45] Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
    Il Seok Daniel Jeong
    Huan Mo
    Anthony Nguyen
    Esther G. Chong
    Hsin Hsiang Clarence Tsai
    Justin Moyers
    Matthew Kim
    Curtis Lacy
    Vivek Shah
    Eric Lau
    Yi Xu
    Huynh Cao
    [J]. Experimental Hematology & Oncology, 9
  • [46] Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
    Marin-Jimenez, Juan A.
    Oliva, Marc
    Martin, Paloma Peinado
    Cabezas-Camarero, Santiago
    Serrahima, Maria Plana
    Masedo, Gonzalo Vazquez
    Borbalas, Alicia Lozano
    Martin, Maria N. Cabrera
    Esteve, Anna
    Moreno, Maria C. Iglesias
    Altamis, Esther Vilajosana
    Hortiguela, Lorena Arribas
    Sanz, Miren Taberna
    Perez-Segura, Pedro
    Mesia, Ricard
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
    Caudell, Jimmy J.
    Torres-Saavedra, Pedro A.
    Rosenthal, David I.
    Axelrod, Rita S.
    Nguyen-Tan, Phuc Felix
    Sherman, Eric J.
    Weber, Randal S.
    Galvin, James M.
    El-Naggar, Adel K.
    Konski, Andre A.
    Echevarria, Michelle I.
    Dunlap, Neal E.
    Shenouda, George
    Singh, Anurag K.
    Beitler, Jonathan J.
    Garsa, Adam
    Bonner, James A.
    Garden, Adam S.
    Algan, Ozer
    Harris, Jonathan
    Le, Quynh-Thu
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (03): : 533 - 543
  • [48] Combined-modality therapy for locoregionally advanced head and neck cancer
    Cmelak, AJ
    Murphy, BA
    Day, T
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (10): : 83 - 91
  • [49] OPTIMIZATION OF COMBINED MODALITY THERAPY FOR LOCOREGIONALLY ADVANCED HEAD AND NECK CANCER
    Vokes, E. E.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 36 - 36
  • [50] Cetuximab and cisplatin for chemotherapy refractory squamous cell cancer of the head and neck
    Burtness, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5440 - 5442
12345